Orally bioavailable Syk inhibitors with activity in a rat PK/PD model

Thoma, Gebhard; Veenstra, Siem; Strang, Ross; Blanz, Joachim; Vangrevelinghe, Eric; Berghausen, Jörg; Lee, Christian C.; Zerwes, Hans-Günter

doi:10.1016/j.bmcl.2015.08.037

Title: Orally bioavailable Syk inhibitors with activity in a rat PK/PD model

Journal Article · 30 September 2015 · Bioorganic and Medicinal Chemistry Letters

DOI: https://doi.org/10.1016/j.bmcl.2015.08.037 · OSTI ID:1250393

Thoma, Gebhard; Veenstra, Siem; Strang, Ross; Blanz, Joachim; Vangrevelinghe, Eric; Berghausen, Jörg; Lee, Christian C.; Zerwes, Hans-Günter

Not Available

View Accepted Manuscript (Publisher)

Cite

Export

Save

Sponsoring Organization:: USDOE

Grant/Contract Number:: AC03-76SF00098

OSTI ID:: 1250393

Journal Information:: Bioorganic and Medicinal Chemistry Letters, Journal Name: Bioorganic and Medicinal Chemistry Letters Journal Issue: 20 Vol. 25; ISSN 0960-894X

Publisher:: ElsevierCopyright Statement

Country of Publication:: United Kingdom

Language:: English

References (32)

A new synthesis of 2,1-benzisothiazoles Singerman, Gary M. Journal of Heterocyclic Chemistry, Vol. 12, Issue 5 https://doi.org/10.1002/jhet.5570120513	journal	October 1975
Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis Taniguchi, T.; Kobayashi, T.; Kondo, J. Journal of Biological Chemistry, Vol. 266, Issue 24 https://doi.org/10.1016/S0021-9258(18)98478-4	journal	August 1991
Protein tyrosine kinase Syk in mast cell signaling Siraganian, Reuben P.; Zhang, Juan; Suzuki, Katsuhiro Molecular Immunology, Vol. 38, Issue 16-18 https://doi.org/10.1016/S0161-5890(02)00068-8	journal	September 2002
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK) Cywin, Charles L.; Zhao, Bao-Ping; McNeil, Daniel W. Bioorganic & Medicinal Chemistry Letters, Vol. 13, Issue 8 https://doi.org/10.1016/S0960-894X(03)00163-X	journal	April 2003
Syk and pTyr'd: Signaling through the B cell antigen receptor Geahlen, Robert L. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Vol. 1793, Issue 7 https://doi.org/10.1016/j.bbamcr.2009.03.004	journal	July 2009
Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor Liddle, John; Atkinson, Francis L.; Barker, Michael D. Bioorganic & Medicinal Chemistry Letters https://doi.org/10.1016/j.bmcl.2011.07.082	journal	August 2011
Pyrazine-based Syk kinase inhibitors Forns, Pilar; Esteve, Cristina; Taboada, Lorena Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 8 https://doi.org/10.1016/j.bmcl.2012.02.087	journal	April 2012
Highly potent aminopyridines as Syk kinase inhibitors Castillo, Marcos; Forns, Pilar; Erra, Montse Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 17 https://doi.org/10.1016/j.bmcl.2012.07.045	journal	September 2012
Syk inhibitors with high potency in presence of blood Thoma, Gebhard; Blanz, Joachim; Bühlmayer, Peter Bioorganic & Medicinal Chemistry Letters, Vol. 24, Issue 10 https://doi.org/10.1016/j.bmcl.2014.03.075	journal	May 2014
Design, synthesis of diaminopyrimidine inhibitors targeting IgE- and IgG-mediated activation of Fc receptor signaling Argade, Ankush; Bhamidipati, Somasekhar; Li, Hui Bioorganic & Medicinal Chemistry Letters, Vol. 25, Issue 10 https://doi.org/10.1016/j.bmcl.2015.03.072	journal	May 2015
Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors Singh, Rajinder; Masuda, Esteban S.; Payan, Donald G. Journal of Medicinal Chemistry, Vol. 55, Issue 8 https://doi.org/10.1021/jm201271b	journal	February 2012
Rational Design of Highly Selective Spleen Tyrosine Kinase Inhibitors Lucas, Matthew C.; Goldstein, David M.; Hermann, Johannes C. Journal of Medicinal Chemistry, Vol. 55, Issue 23 https://doi.org/10.1021/jm301367c	journal	November 2012
Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors Padilla, Fernando; Bhagirath, Niala; Chen, Shaoqing Journal of Medicinal Chemistry, Vol. 56, Issue 4 https://doi.org/10.1021/jm301720p	journal	February 2013
Using Ovality to Predict Nonmutagenic, Orally Efficacious Pyridazine Amides as Cell Specific Spleen Tyrosine Kinase Inhibitors Lucas, Matthew C.; Bhagirath, Niala; Chiao, Eric Journal of Medicinal Chemistry, Vol. 57, Issue 6 https://doi.org/10.1021/jm401982j	journal	February 2014
Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase Currie, Kevin S.; Kropf, Jeffrey E.; Lee, Tony Journal of Medicinal Chemistry, Vol. 57, Issue 9 https://doi.org/10.1021/jm500228a	journal	April 2014
Overcoming Mutagenicity and Ion Channel Activity: Optimization of Selective Spleen Tyrosine Kinase Inhibitors Ellis, J. Michael; Altman, Michael D.; Bass, Alan Journal of Medicinal Chemistry, Vol. 58, Issue 4 https://doi.org/10.1021/jm5018169	journal	February 2015
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design Beno, Brett R.; Yeung, Kap-Sun; Bartberger, Michael D. Journal of Medicinal Chemistry, Vol. 58, Issue 11 https://doi.org/10.1021/jm501853m	journal	March 2015
Discovery and Profiling of a Selective and Efficacious Syk Inhibitor Thoma, Gebhard; Smith, Alexander B.; van Eis, Maurice J. Journal of Medicinal Chemistry, Vol. 58, Issue 4 https://doi.org/10.1021/jm5018863	journal	February 2015
Phenyl Carboxamide Analogues as Spleen Tyrosine Kinase (Syk) Inhibitors Brazeau, Jean-Francois; Rosse, Gerard ACS Medicinal Chemistry Letters, Vol. 5, Issue 4 https://doi.org/10.1021/ml500047f	journal	February 2014
Comprehensive analysis of kinase inhibitor selectivity Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna Nature Biotechnology, Vol. 29, Issue 11 https://doi.org/10.1038/nbt.1990	journal	October 2011
SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond Koretzky, Gary A.; Abtahian, Farhad; Silverman, Michael A. Nature Reviews Immunology, Vol. 6, Issue 1 https://doi.org/10.1038/nri1750	journal	January 2006
The SYK tyrosine kinase: a crucial player in diverse biological functions Mócsai, Attila; Ruland, Jürgen; Tybulewicz, Victor L. J. Nature Reviews Immunology, Vol. 10, Issue 6 https://doi.org/10.1038/nri2765	journal	May 2010
Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle Hochegger, Helfrid; Hégarat, Nadia; Pereira-Leal, Jose B. Open Biology, Vol. 3, Issue 3 https://doi.org/10.1098/rsob.120185	journal	March 2013
The tyrosine kinase network regulating mast cell activation Gilfillan, Alasdair M.; Rivera, Juan Immunological Reviews, Vol. 228, Issue 1 https://doi.org/10.1111/j.1600-065X.2008.00742.x	journal	March 2009
Autoinhibition and adapter function of Syk Kulathu, Yogesh; Grothe, Gesina; Reth, Michael Immunological Reviews, Vol. 232, Issue 1 https://doi.org/10.1111/j.1600-065X.2009.00837.x	journal	November 2009
R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation Braselmann, Sylvia; Taylor, Vanessa; Zhao, Haoran Journal of Pharmacology and Experimental Therapeutics, Vol. 319, Issue 3 https://doi.org/10.1124/jpet.106.109058	journal	August 2006
Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis Coffey, Greg; DeGuzman, Francis; Inagaki, Mayuko Journal of Pharmacology and Experimental Therapeutics, Vol. 340, Issue 2 https://doi.org/10.1124/jpet.111.188441	journal	October 2011
Inhibition of Spleen Tyrosine Kinase Attenuates Allergen-Mediated Airway Constriction Moy, Lily Y.; Jia, Yanlin; Caniga, Michael American Journal of Respiratory Cell and Molecular Biology, Vol. 49, Issue 6 https://doi.org/10.1165/rcmb.2013-0200OC	journal	December 2013
An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola Moore, William J.; Richard, David; Thorarensen, Atli Expert Opinion on Therapeutic Patents, Vol. 20, Issue 12 https://doi.org/10.1517/13543776.2010.534459	journal	November 2010
Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 – 2013 Norman, Peter Expert Opinion on Therapeutic Patents, Vol. 24, Issue 5 https://doi.org/10.1517/13543776.2014.890184	journal	February 2014
Spleen tyrosine kinase: An Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases Ghosh, Debjani; Tsokos, George C. Autoimmunity, Vol. 43, Issue 1 https://doi.org/10.3109/08916930903374717	journal	December 2009
Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations? Lucas, Matthew C.; Tan, Seng-Lai Future Medicinal Chemistry, Vol. 6, Issue 16 https://doi.org/10.4155/fmc.14.126	journal	October 2014

Similar Records

Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK)

Journal Article · 2016 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1414873

Lam, Betty; Arikawa, Yasuyoshi; Cramlett, Joshua; +19 more

From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors

Journal Article · 2017 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1413842

Liang, Jun; Labadie, Sharada; Zhang, Birong; +23 more

Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases

Journal Article · 2021 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1815229

Ji, Zhiqin; Clark, Richard F.; Bhat, Vikram; +15 more

Title: Orally bioavailable Syk inhibitors with activity in a rat PK/PD model

Citation Formats

References (32)

Similar Records

Related Subjects